Customers Bancorp, Inc.

CUBI

CIK 0001488813 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$355M
↑+7.7% +$25Mvs FY2024 (Q4)
Operating Income
$355M
↑+7.7% +$25Mvs FY2024 (Q4)
Net Income
$74M
↑+176.8% +$48Mvs FY2024 (Q4)
Gross Profit
$355M
↑+7.7% +$25Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
24/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover 0.06x (1.0+ = capital-efficient)
  • Growth
    42Revenue YoY +7.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CUBI's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$247.46
Total enterprise IV
$8.27B
Diluted shares
0.03B
Terminal PV
$6.00B (72% of total)
Year-5 FCF
$707M
YearProjected FCFDiscounted PV
+1$520M$472M
+2$561M$464M
+3$606M$455M
+4$654M$447M
+5$707M$439M
Terminal$9.66B$6.00B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$14M
investment in PP&E
Stock buybacks (TTM)
$6M
share count reduction
Stock-based comp (TTM)
$18M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$24.90B
everything owned
Total liabilities
$22.78B
everything owed
Stockholders' equity
$2.12B
shareholder claim
Net debt
$-4.41B
Net cash position ($4.41B)

Recent performance · 66 quarters

Revenue↑+7.7% +$25M
$355M
Net Income↑+176.8% +$48M
$74M
Free Cash Flow↓-10.4% -$14M
$119M

Drill down